相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers
Xabier Agirre et al.
GENOME RESEARCH (2015)
The DAPK family: a structure-function analysis
Ruth Shiloh et al.
APOPTOSIS (2014)
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
S. Vincent Rajkumar et al.
LANCET ONCOLOGY (2014)
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)
E. M. Ocio et al.
LEUKEMIA (2014)
IMWG consensus on risk stratification in multiple myeloma
W. J. Chng et al.
LEUKEMIA (2014)
Signaling through cyclin D-dependent kinases
Y. J. Choi et al.
ONCOGENE (2014)
Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1
P. Wang et al.
ONCOGENE (2014)
Global Epigenetic Regulation of MicroRNAs in Multiple Myeloma
Wenjing Zhang et al.
PLOS ONE (2014)
The role of epigenetics in the biology of multiple myeloma
K. Dimopoulos et al.
BLOOD CANCER JOURNAL (2014)
Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients
B. A. Walker et al.
BLOOD CANCER JOURNAL (2014)
Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma
Martin F. Kaiser et al.
BLOOD (2013)
Inactivation of TP53 correlates with disease progression and low miR-34a expression in previously treated chronic lymphocytic leukemia patients
Annika Dufour et al.
BLOOD (2013)
Hypodiploid multiple myeloma is characterized by more aggressive molecular markers than non-hyperdiploid multiple myeloma
Scott Van Wier et al.
HAEMATOLOGICA (2013)
Myeloma Is Characterized by Stage-Specific Alterations in DNA Methylation That Occur Early during Myelomagenesis
Christoph J. Heuck et al.
JOURNAL OF IMMUNOLOGY (2013)
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
C. Fernandez de Larrea et al.
LEUKEMIA (2013)
Methylation-mediated repression of microRNA 129-2 enhances oncogenic SOX4 expression in HCC
Xiangmei Chen et al.
LIVER INTERNATIONAL (2013)
Concise Drug Review: Azacitidine and Decitabine
Ellen J. B. Derissen et al.
ONCOLOGIST (2013)
WNT signalling pathways as therapeutic targets in cancer
Jamie N. Anastas et al.
NATURE REVIEWS CANCER (2013)
DNA methylation of microRNA genes in multiple myeloma
Kwan Yeung Wong et al.
CARCINOGENESIS (2012)
Wnt/β-Catenin Signaling and Disease
Hans Clevers et al.
CELL (2012)
Specificity of Dnmt1 for Methylation of Hemimethylated CpG Sites Resides in Its Catalytic Domain
Pavel Bashtrykov et al.
CHEMISTRY & BIOLOGY (2012)
CpG island methylation status of miRNAs in esophageal squamous cell carcinoma
Xuedan Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies
Pasquale Sansone et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial
K. D. Boyd et al.
LEUKEMIA (2012)
Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer
Norimitsu Tanaka et al.
LUNG CANCER (2012)
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Peter A. Jones
NATURE REVIEWS GENETICS (2012)
Long non-coding RNAs and cancer: a new frontier of translational research?
R. Spizzo et al.
ONCOGENE (2012)
Molecular analysis of RAS-RAF tyrosine-kinase signaling pathway alterations in patients with plasma cell myeloma
V. Grossmann et al.
BLOOD CANCER JOURNAL (2012)
Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma
Brian A. Walker et al.
BLOOD (2011)
Epigenetic inactivation of the MIR34B/C in multiple myeloma
Kwan Yeung Wong et al.
BLOOD (2011)
Epigenetic silencing of MIR203 in multiple myeloma
Kwan-Yeung Wong et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Epigenetic Silencing of MicroRNA-203 Dysregulates ABL1 Expression and Drives Helicobacter-Associated Gastric Lymphomagenesis
Vanessa J. Craig et al.
CANCER RESEARCH (2011)
Epigenetic inactivation of the hsa-miR-203 in haematological malignancies
Chor Sang Chim et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
Chor Sang Chim et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
MicroRNA signatures characterize multiple myeloma patients
S. L. Corthals et al.
LEUKEMIA (2011)
The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma
S. K. Martin et al.
LEUKEMIA (2011)
Diagnosis of Smoldering Multiple Myeloma
S. Vincent Rajkumar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Epigenetic Inactivation of the miR-124-1 in Haematological Malignancies
Kwan Yeung Wong et al.
PLOS ONE (2011)
Could DNA methylation become a useful measure for multiple myeloma prognoses?
Brian A. Walker et al.
EXPERT REVIEW OF HEMATOLOGY (2011)
DNA methylation of tumor suppressor miRNA genes: a lesson from the miR-34 family
Kwan Yeung Wong et al.
EPIGENOMICS (2011)
Cyclin D as a therapeutic target in cancer
Elizabeth A. Musgrove et al.
NATURE REVIEWS CANCER (2011)
Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer
Ruizhe Shen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Interplay between microRNAs and the epigenetic machinery: An intricate network
Marilena V. Iorio et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value
Brian A. Walker et al.
BLOOD (2010)
Hematopoietic stem cell transplantation for multiple myeloma beyond 2010
Joan Blade et al.
BLOOD (2010)
被撤回的出版物: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development (Retracted article. See vol. 40, pg. 1442, 2022)
Flavia Pichiorri et al.
CANCER CELL (2010)
miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma
Mayuko Furuta et al.
CARCINOGENESIS (2010)
Epigenetic inactivation of the miR-34a in hematological malignancies
C. S. Chim et al.
CARCINOGENESIS (2010)
miR-129 regulates cell proliferation by downregulating Cdk6 expression
Junjie Wu et al.
CELL CYCLE (2010)
Frequent Downregulation of miR-34 Family in Human Ovarian Cancers
David C. Corney et al.
CLINICAL CANCER RESEARCH (2010)
The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia
Eleftheria Hatzimichael et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Down-Regulated MicroRNA-152 Induces Aberrant DNA Methylation in Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting DNA Methyltransferase 1
Jinfeng Huang et al.
HEPATOLOGY (2010)
Methylation status of nine tumor suppressor genes in multiple myeloma
Esteban Braggio et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Updated survivals and prognostic factor analysis in myeloma treated by a staged approach use of bortezomib/thalidomide/dexamethasone in transplant eligible patients
Chor Sang Chim
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer
Saskia M. Wilting et al.
MOLECULAR CANCER (2010)
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
R. A. Kyle et al.
LEUKEMIA (2010)
DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer
Amy Sharma et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2010)
Orphan CpG Islands Identify Numerous Conserved Promoters in the Mammalian Genome
Robert S. Illingworth et al.
PLOS GENETICS (2010)
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1
Ramiro Garzon et al.
BLOOD (2009)
Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial
Thorsten Zenz et al.
BLOOD (2009)
Epigenetic dysregulation of secreted Frizzled-related proteins in multiple myeloma
E. Jost et al.
CANCER LETTERS (2009)
Epigenetic Repression of microRNA-129-2 Leads to Overexpression of SOX4 Oncogene in Endometrial Cancer
Yi-Wen Huang et al.
CANCER RESEARCH (2009)
Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro
Lars Dyrskjot et al.
CANCER RESEARCH (2009)
Epigenetic Silencing of the Tumor Suppressor MicroRNA Hsa-miR-124a Regulates CDK6 Expression and Confers a Poor Prognosis in Acute Lymphoblastic Leukemia
Xabier Agirre et al.
CANCER RESEARCH (2009)
miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer
Elena Gallardo et al.
CARCINOGENESIS (2009)
MicroRNA Control in the Immune System: Basic Principles
Changchun Xiao et al.
CELL (2009)
Epigenetic regulation of microRNA expression in colorectal cancer
Eva Bandres et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation
M. K. Dijkstra et al.
LEUKEMIA (2009)
Bone marrow microenvironment and the identification of new targets for myeloma therapy
K. Podar et al.
LEUKEMIA (2009)
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
R. Fonseca et al.
LEUKEMIA (2009)
miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities
M. Mraz et al.
LEUKEMIA (2009)
Long non-coding RNAs: insights into functions
Tim R. Mercer et al.
NATURE REVIEWS GENETICS (2009)
Linking DNA methylation and histone modification: patterns and paradigms
Howard Cedar et al.
NATURE REVIEWS GENETICS (2009)
Causes and consequences of microRNA dysregulation in cancer
Carlo M. Croce
NATURE REVIEWS GENETICS (2009)
von Hippel-Lindau Methylation Status in Patients with Multiple Myeloma: A Potential Predictive Factor for the Development of Bone Disease
Eleftheria Hatzimichael et al.
CLINICAL LYMPHOMA & MYELOMA (2009)
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells
Joachim Silber et al.
BMC MEDICINE (2008)
SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2′deoxycytidine to increase SPARC expression and improve therapy response
S. Cheetham et al.
BRITISH JOURNAL OF CANCER (2008)
Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression
Maria J. Bueno et al.
CANCER CELL (2008)
Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer
Minoru Toyota et al.
CANCER RESEARCH (2008)
Clinical and biological significance of RAS mutations in multiple myeloma
W. J. Chng et al.
LEUKEMIA (2008)
Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?
Witold Filipowicz et al.
NATURE REVIEWS GENETICS (2008)
A microRNA DNA methylation signature for human cancer metastasis
Amaia Lujambio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
miR-34a repression of SIRT1 regulates apoptosis
Munekazu Yamakuchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Promoter hypermethylation of the MEG3 (DLK1/MEG3) imprinted gene in multiple myeloma
Leonidas Benetatos et al.
CLINICAL LYMPHOMA & MYELOMA (2008)
Gene Hypermethylation in Multiple Myeloma: Lessons from a Cancer Pathway Approach
Chor S. Chim et al.
CLINICAL LYMPHOMA & MYELOMA (2008)
Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma
C. S. Chim et al.
LEUKEMIA (2007)
The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel
Ahmed Ashour Ahmed et al.
CANCER CELL (2007)
Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma
David Gonzalez et al.
BLOOD (2007)
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B
Muller Fabbri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth
David C. Corney et al.
CANCER RESEARCH (2007)
Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis
Yan P. Yu et al.
CANCER RESEARCH (2007)
p53-mediated activation of miRNA34 candidate tumor-suppressor genes
Guido T. Bommer et al.
CURRENT BIOLOGY (2007)
Differential regulation of microRNAs by p53 revealed by massively parallel Sequencing -: miR-34a is a p53 target that induces apoptosis and G1-arrest
Valery Tarasov et al.
CELL CYCLE (2007)
Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma
Robert A. Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Tsung-Cheng Chang et al.
MOLECULAR CELL (2007)
Transcriptional activation of miR-34a contributes to p53-mediated apoptosis
Nina Raver-Shapira et al.
MOLECULAR CELL (2007)
Epigenetic dysregulation of the death-associated protein kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in multiple myeloma
Chor-Sang Chim et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome
Herve Avet-Loiseau et al.
BLOOD (2007)
Genetic unmasking of an epigenetically silenced microRNA in human cancer cells
Amaia Lujambio et al.
CANCER RESEARCH (2007)
Aberrant gene methylation implicated in the progression of monoclonal gammopathy of undetermined significance to multiple myeloma
Chor-Sang Chim et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling
Wee J. Chng et al.
CANCER RESEARCH (2007)
Cancer epigenomics: DNA methylomes and histone-modification maps
Manel Esteller
NATURE REVIEWS GENETICS (2007)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation
Ichiro Hanamura et al.
BLOOD (2006)
Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells
Yoshimasa Saito et al.
CANCER CELL (2006)
Prognostic factors for hyperdiploid-myeloma:: effects of chromosome 13 deletions and IgH translocations
W Chng et al.
LEUKEMIA (2006)
Oncomirs - microRNAs with a role in cancer
A Esquela-Kerscher et al.
NATURE REVIEWS CANCER (2006)
A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters
S Saxonov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Epigenetic therapy of cancer: past, present and future
CB Yoo et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
MicroRNA functions in animal development and human disease
I Alvarez-Garcia et al.
DEVELOPMENT (2005)
DNA methylation and human disease
KD Robertson
NATURE REVIEWS GENETICS (2005)
Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma
PL Bergsagel et al.
BLOOD (2005)
Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors
J Reddy et al.
ONCOGENE (2005)
Illegitimate WNT signaling promotes proliferation of multiple myeloma cells
PWB Derksen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The JAK/STAT signaling pathway
JS Rawlings et al.
JOURNAL OF CELL SCIENCE (2004)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
SOCS1 and SHP1 hypermethylation in multiple myeloma:: implications for epigenetic activation of the Jak/STAT pathway
CS Chim et al.
BLOOD (2004)
DNA-methylation analysis identifies the E-cadherin gene as a potential marker of disease progression in patients with monoclonal gammopathies
S Seidl et al.
CANCER (2004)
The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma
E Tian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Disruption of INK4/CDK/Rb cell cycle pathway by gene hypermethylation in multiple myeloma and MGUS
CS Chim et al.
LEUKEMIA (2003)
Mechanisms of disease: Gene silencing in cancer in association with promoter hypermethylation
JG Herman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma
R Fonseca et al.
BLOOD (2003)
MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms
Y Zeng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
SOCS-1 gene methylation is frequent but does not appear to have prognostic value in patients with multiple myeloma
S Depil et al.
LEUKEMIA (2003)
SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma
O Galm et al.
BLOOD (2003)
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma
CS Debes-Marun et al.
LEUKEMIA (2003)
DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells
MF Robert et al.
NATURE GENETICS (2003)
Hypermethylation of gene promoters in hematological neoplasia
CS Chim et al.
HEMATOLOGICAL ONCOLOGY (2002)
Methylation is an inactivating mechanism of the p16 gene in multiple myeloma associated with high plasma cell proliferation and short survival
MV Mateos et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells
I Rhee et al.
NATURE (2002)
Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation
H Avet-Loiseau et al.
BLOOD (2002)
A long-term study of prognosis in monoclonal gammopathy of undetermined significance
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Multiple myeloma: Evolving genetic events and host interactions
WM Kuehl et al.
NATURE REVIEWS CANCER (2002)
DNA methylation patterns and epigenetic memory
A Bird
GENES & DEVELOPMENT (2002)
Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors
H Avet-Loiseau et al.
BLOOD (2001)
Hypodiploidy is a major prognostic factor in multiple myeloma
NV Smadja et al.
BLOOD (2001)
Chromosome translocations in multiple myeloma
PL Bergsagel et al.
ONCOGENE (2001)
p16INK4a and p15INK4b gene methylations in plasma cells from monoclonal gammopathy of undetermined significance
G Guillerm et al.
BLOOD (2001)
DNA methylation, chromatin inheritance, and cancer
MR Rountree et al.
ONCOGENE (2001)
Chromosomal stability and the DNA double-stranded break connection
DC van Gent et al.
NATURE REVIEWS GENETICS (2001)
Large-scale human promoter mapping using CpG islands
IP Ioshikhes et al.
NATURE GENETICS (2000)
分享论文
